Related Experiment Video
Updated: Nov 30, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
2020 Innovation-Based Optimism for Lung Cancer Outcomes
Erin L Schenk1, Tejas Patil1, Jose Pacheco1
1Division of Medical Oncology, University of Colorado Cancer Center, Aurora, Colorado, USA.
Abstract:
Lung cancer is the leading cause of cancer death in both males and females in the U.S. and worldwide. Owing to advances in prevention, screening/early detection, and therapy, lung cancer mortality rates are decreasing and survival rates are increasing. These innovations are based on scientific discoveries in imaging, diagnostics, genomics, molecular therapy, and immunotherapy. Outcomes have improved in all histologies and stages. This review provides information on the clinical implications of these innovations that are practical for the practicing physicians, especially oncologists of all specialities who diagnose and treat patients with lung cancer. IMPLICATIONS FOR PRACTICE: Lung cancer survival rates have improved because of new prevention, screening, and therapy methods. This work provides a review of current standards for each of these areas, including targeted and immunotherapies. Treatment recommendations are provided for all stages of lung cancer.
Insights
Lung cancer survival is improving due to advances in prevention, screening, and therapies like targeted and immunotherapies. This review details clinical implications for physicians treating all lung cancer stages.
Area of Science:
- Oncology
- Pulmonology
- Medical Innovations
Background:
- Lung cancer remains a leading cause of cancer death globally.
- Recent scientific discoveries are improving patient outcomes.
- Advances span prevention, screening, diagnostics, and treatment.
Purpose of the Study:
- To review clinical implications of recent lung cancer innovations.
- To provide practical information for practicing physicians and oncologists.
- To cover current standards in prevention, screening, and therapy.
Main Methods:
- Review of current scientific literature and clinical practice guidelines.
- Synthesis of information on imaging, diagnostics, genomics, molecular therapy, and immunotherapy.
- Focus on practical applications for physicians treating lung cancer.
Main Results:
- Improved lung cancer survival rates across all histologies and stages.
- Significant progress in targeted therapy and immunotherapy.
- Established standards for prevention, screening, and early detection.
Conclusions:
- Innovations in lung cancer care are leading to better outcomes.
- Physicians benefit from understanding the clinical implications of these advances.
- Comprehensive treatment recommendations are available for all lung cancer stages.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Treatment Resistant Cancers
Tumor Immunotherapy
Cancer Prevention
Some...
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

